ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

Youth Smoking Begins To Decline, NCI Says

April 5, 2002

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006

Longer Chemo Regimen Offers Better DFS For Premenopausal Breast Cancer

January 31, 2003

House Labor-HHS-Ed/ Committee Concerned About Cut In Prevention, Construction Budget

March 20, 1992

In Brief: Hedlund To Head Prostate Cancer Coalition; USCF Forms Human Genetics Program

July 25, 1997

Guest Editorial: The Academic Difference: George Weiner On How America’s Cancer Centers Are More Valuable Than Ever

October 31, 2014